Search
Protagenic Therapeutics Inc
PTIXAdd to Watchlist
0.740USD
0.0000.00%
Market hours （ET）Quotes delayed by 15 min
633.57KMarket Cap
43.10P/E TTM
Risk Assessment
Currency: USD Updated: 2026-01-02No risk assessment score is currently available for Protagenic Therapeutics Inc. The Biotechnology & Medical Research industry's average is 3.49. The company's beta value is 1.11. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.
Beta vs S&P 500 index
1.14
VaR
+12.00%
240-Day Maximum Drawdown
+93.33%
240-Day Volatility
+226.39%
Return
Best Daily Return
60 days
+15.22%
120 days
+86.84%
5 years
+266.67%
Worst Daily Return
60 days
-43.08%
120 days
-43.08%
5 years
-43.08%
Sharpe Ratio
60 days
-4.37
120 days
-1.27
5 years
+0.17
Risk Assessment
Maximum Drawdown
240 days
+93.33%
3 years
+100.00%
5 years
--
Return-to-Drawdown Ratio
240 days
-0.94
3 years
-0.32
5 years
--
Skewness
240 days
+8.33
3 years
+10.60
5 years
+9.56
Volatility
Realised Volatility
240 days
+226.39%
5 years
--
Standardised True Range
240 days
+67.85%
5 years
--
Downside Risk-Adjusted Return
120 days
-240.17%
240 days
-240.17%
Maximum Daily Upside Volatility
60 days
+73.96%
Maximum Daily Downside Volatility
60 days
+107.27%
Liquidity
Average Turnover Rate
60 days
+8418.07%
120 days
+12583.36%
5 years
--
Turnover Deviation
20 days
-100.00%
60 days
-100.00%
120 days
-100.00%